Hawkeye Digital posts $681K in first quarterly revenue
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Hawkeye Digital, Inc. (HWKE) reported $681,290 in advisory revenue for the quarter ended September 30, 2026, its first revenue, all from one Omnitek engagement; $300,000 was cash and $381,290 was Omnitek warrants measured at fair value. Omnitek instruments produced a $1,614,095 unrealized gain; net loss was $(146,911), versus $(101,533) a year earlier, while operating loss was $(1,771,773). The instruments’ $2,545,385 fair value uses Level 3 inputs and depends on Omnitek’s thinly traded stock price.
Cash fell to $1,190,461 from $2,105,343 at June 30, 2026, and operating activities used $354,882. The Omnitek securities are restricted and not readily convertible into cash. Management’s existing-cash projection excludes potential acquisition costs and salaries; the four employees deferred their $900,000 aggregate annual salaries until the later of January 1, 2027 and additional fundraising. On its projection, management concluded that conditions did not raise substantial doubt about continued operations, but said additional capital is needed for its strategy and potential acquisition. Disclosure controls were ineffective as of September 30, 2026, with material weaknesses unremediated.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointAdjusted EBITDA (non-GAAP) was $320,102, versus $(33,507) a year earlier.
Negative
- Major pointDisclosure controls were ineffective as of September 30, 2026, with material weaknesses unremediated.
- Moderate pointOperating cash used was $354,882, compared with $59,611 a year earlier.
- Minor pointNet loss was $(146,911), compared with $(101,533) in the prior-year quarter.
Filing Explained
The completed cashless exercise diluted existing holders’ percentage ownership and brought no cash into Hawkeye.
In
Hawkeye also entered a tokenization agreement with Securitize on
Key Figures
Key Terms
noncash consideration financial
Level 3 financial
Black-Scholes option-pricing model financial
Rule 144 holding period regulatory
cashless basis financial
material weakness technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much revenue and net loss did HWKE report for the September 2026 quarter?
How much cash and working capital did HWKE have at September 30, 2026?
Why did HWKE say its disclosure controls were ineffective?
When do HWKE's $900,000 annual salaries begin?
AI-generated analysis. How Rhea-AI works. Not financial advice.
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended
OR
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ____________ to ____________
Commission File Number:
| (Exact Name of Registrant as Specified in Its Charter) |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
| (Address of principal executive offices) | (Zip Code) |
(
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Exchange Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| None | N/A | N/A |
Securities registered pursuant to Section 12(g) of the Exchange Act:
Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days.
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| ☒ | Smaller reporting company | ||
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes ☐ No ☐
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐
No
The number of shares outstanding of each of the
issuer’s classes of common equity as of November 12, 2026, were
TABLE OF CONTENTS
| Page | ||
| PART I. | FINANCIAL INFORMATION | 3 |
| Item 1. | Financial Statements | 3 |
| Condensed Balance Sheets as of September 30, 2026 (Unaudited) and June 30, 2026 (audited) | 3 | |
| Condensed Statements of Operations for the Three Months Ended September 30, 2026 and 2025 (Unaudited) | 4 | |
| Condensed Statements of Changes in Stockholders’ Equity (Deficit) for the Three Months Ended September 30, 2026 and 2025 (Unaudited) | 5 | |
| Condensed Statements of Cash Flows for the Three Months Ended September 30, 2026 and 2025 (Unaudited) | 6 | |
| Notes to the Condensed Financial Statements (Unaudited) | 7 | |
| Special Note Regarding Forward-Looking Statements | 20 | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 21 |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 31 |
| Item 4. | Controls and Procedures | 31 |
| PART II. | OTHER INFORMATION | 33 |
| Item 1. | Legal Proceedings | 33 |
| Item 1A. | Risk Factors | 33 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 36 |
| Item 3. | Defaults Upon Senior Securities | 36 |
| Item 4. | Mine Safety Disclosures | 36 |
| Item 5. | Other Information | 36 |
| Item 6. | Exhibits | 37 |
| Signatures | 38 |
| 2 |
PART I—FINANCIAL INFORMATION
Item 1. Financial Statements.
HAWKEYE DIGITAL, INC.
Condensed Balance Sheets
(Unaudited) September 30, | (Audited) June 30, 2026 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash | $ | $ | ||||||
| Prepaid expenses (Note 7) | ||||||||
| Deferred offering costs (Note 8) | ||||||||
| Investments, at fair value (Note 5) | ||||||||
| Total current assets | ||||||||
| Equity method investment – Rift Cyber LLC (Note 6) | ||||||||
| Total assets | $ | $ | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable and accrued liabilities (Note 9) | $ | $ | ||||||
| Total current liabilities | ||||||||
| Commitments and contingencies (Note 13) | – | |||||||
| Stockholders’ equity: | ||||||||
| Preferred stock, $ | ||||||||
| Common stock, $ | ||||||||
| Additional paid-in capital | ||||||||
| Stock to be issued ( | ||||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Total stockholders’ equity | ||||||||
| Total liabilities and stockholders’ equity | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
| 3 |
HAWKEYE DIGITAL, INC.
Condensed Statements of Operations
(Unaudited)
| Three Months Ended September 30, | ||||||||
| 2026 | 2025 | |||||||
| Revenue (Note 4) | $ | $ | ||||||
| Operating expenses: | ||||||||
| Professional fees (1) | ||||||||
| Acquisition-related costs | ||||||||
| Sales and marketing (1) | ||||||||
| General and administrative | ||||||||
| Total operating expenses | ||||||||
| Loss from operations | ( | ) | ( | ) | ||||
| Other income (expense), net: | ||||||||
| Interest income | ||||||||
| Interest expense | ( | ) | ||||||
| Interest expense – related party | ( | ) | ||||||
| Unrealized gain on investments (Note 5) | ||||||||
| Total other income (expense), net | ( | ) | ||||||
| Loss before provision for income taxes | ( | ) | ( | ) | ||||
| Provision for income taxes (Note 12) | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Net loss per common share – basic and diluted (Note 14) | $ | ( | ) | $ | ( | ) | ||
| Weighted-average common shares outstanding – basic | ||||||||
| Weighted-average common shares outstanding – diluted | ||||||||
| (1) Includes stock-based compensation as follows: | ||||||||
| Professional fees | $ | $ | ||||||
| Sales and marketing |
The accompanying notes are an integral part of these unaudited condensed financial statements.
| 4 |
HAWKEYE DIGITAL, INC.
Condensed Statements of Changes in Stockholders’ Equity (Deficit)
(Unaudited)
Three Months Ended September 30, 2026
| Common Shares | Common Stock Amount | Additional Paid-in Capital | Stock to be Issued | Accumulated Deficit | Total Equity | |||||||||||||||||||
| Balance, June 30, 2026 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||
| Advisory warrants issued for cash and services (Note 8) | – | – | – | – | ||||||||||||||||||||
| Common stock to be issued for investor relations consulting services (Note 11) | – | – | – | – | ||||||||||||||||||||
| Net loss | – | – | – | – | ( | ) | ( | ) | ||||||||||||||||
| Balance, September 30, 2026 | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||
Three Months Ended September 30, 2025
| Common Shares | Common Stock Amount | Additional Paid-in Capital | Stock to be Issued | Accumulated Deficit | Total Equity (Deficit) | |||||||||||||||||||
| Balance, June 30, 2025 | $ | $ | $ | $ | ( | ) | $ | ( | ) | |||||||||||||||
| Reclassification of accounts payable – related party to stock to be issued | – | – | – | – | ||||||||||||||||||||
| Net loss | – | – | – | – | ( | ) | ( | ) | ||||||||||||||||
| Balance, September 30, 2025 | $ | $ | $ | $ | ( | ) | $ | ( | ) | |||||||||||||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
| 5 |
HAWKEYE DIGITAL, INC.
Condensed Statements of Cash Flows
(Unaudited)
| Three Months Ended September 30, | ||||||||
| 2026 | 2025 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Unrealized gain on investments | ( | ) | ||||||
| Share-based compensation – investor relations consultant shares (Note 11) | ||||||||
| Share-based payments – advisory warrants (Note 8) | ||||||||
| Noncash consideration received for advisory services | ( | ) | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Prepaid expenses | ( | ) | ||||||
| Accounts payable and accrued liabilities | ( | ) | ||||||
| Accrued interest – related party | ||||||||
| Net cash used in operating activities | ( | ) | ( | ) | ||||
| Cash flows from investing activities: | ||||||||
| Purchase of investments – Omnitek warrants | ( | ) | ||||||
| Investment in equity method investee – Rift Cyber LLC | ( | ) | ||||||
| Net cash used in investing activities | ( | ) | ( | ) | ||||
| Cash flows from financing activities: | ||||||||
| Proceeds from sale of common stock purchase warrants | ||||||||
| Payment of deferred offering costs (Note 8) | ( | ) | ||||||
| Proceeds from related-party promissory note | ||||||||
| Net cash provided by (used in) financing activities | ( | ) | ||||||
| Net change in cash | ( | ) | ( | ) | ||||
| Cash, beginning of period | ||||||||
| Cash, end of period | $ | $ | ||||||
| Supplemental cash flow information: | ||||||||
| Cash paid for interest | $ | $ | ||||||
| Cash paid for income taxes | $ | $ | ||||||
| Noncash investing and financing activities: | ||||||||
| Omnitek warrants received as noncash consideration for advisory services | $ | $ | ||||||
| Omnitek option received in the Omnitek transaction | $ | $ | ||||||
| Reclassification of accounts payable – related party to stock to be issued | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
| 6 |
HAWKEYE DIGITAL, INC.
Notes to the Condensed Financial Statements
(Unaudited)
Note 1 - Description of business
Organization and nature of business
Hawkeye Digital, Inc. (the “Company”),
formerly Hawkeye Systems, Inc., is a Nevada corporation incorporated on May 15, 2018. On August 20, 2026, the Company’s Amended
and Restated Articles of Incorporation, which had been approved by the holders of a majority of the voting power of the Company’s
common stock on June 17, 2026, became effective. Among other things, they changed the Company’s name to Hawkeye Digital, Inc. and
increased authorized common stock from
Following the change in control described below, the Company operates as a private equity and corporate advisory firm conducting merchant banking services in digital assets and other frontier verticals in financial services and technology. The Company earned its first advisory fee revenue during the three months ended September 30, 2026 (Note 4, Revenue). As of September 30, 2026, the Company had not acquired a registered broker-dealer, registered investment adviser or other operating business.
The Company holds a 19.9% membership interest in Rift Cyber LLC (“Rift”), a Nevada limited liability company holding intellectual property relative to certain physical security and cybersecurity. Rift has not generated revenue since formation (Note 6, Equity method investment).
During the quarter, the Company incurred costs in pursuit of a potential business acquisition pursuant to a non-binding letter of intent. See Note 3, Liquidity.
Change in control
Effective April 1, 2026, the Company underwent a change in control as a result of a series of related transactions with Hawkeye Holdco LLC, a Wyoming limited liability company (“HH”), and Steve Hall, which were completed in June 2026 and are described in Note 1, Description of business, of the 2026 Form 10-K. As a result of those transactions, HH beneficially owned approximately 91% of the Company’s outstanding common stock as of September 30, 2026 and June 30, 2026, and HH has the right under an Investor Rights Agreement to designate four of the five members of the Board of Directors. Martin Sumichrast, Chairman of the Board, is the manager of MCIMAC, LLC, which is the manager of HH, and David Wachsman, President, and Q. Byron Hamlett, Chief Financial Officer, hold minority membership interests in HH (Note 10, Related party transactions). The change in control resulted in an ownership change under Section 382 of the Internal Revenue Code (Note 12, Income taxes).
Principal office
The Company’s principal executive offices are located at 350 Lincoln Road, 2nd Floor, Miami Beach, Florida 33139, under a month-to-month mail-and-meeting arrangement. See Note 13, Commitments and contingencies.
Note 2 – Summary of significant accounting policies
Basis of presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations. In the opinion of management, the accompanying condensed financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the Company’s financial position as of September 30, 2026 and its results of operations and cash flows for the three months ended September 30, 2026 and 2025. The condensed balance sheet as of June 30, 2026 has been derived from the audited financial statements as of that date. These condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2026, filed with the SEC on September 11, 2026 (the “2026 Form 10-K”). The results of operations for the three months ended September 30, 2026 are not necessarily indicative of the results to be expected for the year ending June 30, 2027 or any other period.
The Company has no subsidiaries. Its
| 7 |
Use of estimates
The preparation of financial statements in
conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets,
liabilities, revenue and expenses and related disclosures. The estimates that are most significant to these condensed financial
statements are the fair value of the Omnitek warrants and option received as consideration and held as investments (Note 4, Revenue,
and Note 5, Investments and fair value measurements); the grant-date fair value of the advisory warrants (Note 8, Advisory warrants
and deferred offering costs) and of the
Reclassifications
Certain prior-period amounts have been reclassified to conform to the current-period presentation, including the presentation of “Selling, general and administrative” expense previously reported for the three months ended September 30, 2025 as “General and administrative,” consistent with the captions used in the 2026 Form 10-K. The reclassifications had no effect on previously reported net loss, total assets, total liabilities or stockholders’ deficit.
Significant accounting policies
The Company’s significant accounting policies are described in Note 2, Summary of significant accounting policies, of the 2026 Form 10-K. Except as described below, there have been no material changes to those policies during the three months ended September 30, 2026. The following policies became significant during the quarter as a result of new transactions.
Revenue recognition
The Company recognizes revenue under ASC 606, Revenue from Contracts with Customers, when it transfers control of promised advisory services to a customer, in the amount of consideration to which it expects to be entitled. Noncash consideration, including warrants and options to acquire a customer’s equity securities, is measured at its estimated fair value at contract inception. Changes in the fair value of noncash consideration after contract inception that result from the form of the consideration are not included in the transaction price and are recognized in other income (expense). The Company evaluates each advisory engagement to identify the contract and the promised services. An engagement generally contains a single performance obligation, because the advisory services are highly interrelated and are not distinct within the context of the contract. The transaction price consists of fixed cash fees and noncash consideration. Fees that are contingent on the outcome of a client transaction are variable consideration and are included in the transaction price only to the extent that it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty is resolved. The Company evaluates the criteria in ASC 606-10-25-27 to determine whether each performance obligation is satisfied over time or at a point in time. For the Omnitek engagement, those criteria were not met, and the performance obligation was satisfied at a point in time, on September 29, 2026, when the services were completed and the Company obtained a present right to payment (Note 4, Revenue).
Investments, at fair value
Warrants and options to acquire equity securities of other entities are measured at fair value, with changes in fair value recognized in earnings as unrealized gain (loss) on investments. The Omnitek warrants (Warrant 2026-01 and Warrant 2026-02, Note 5, Investments and fair value measurements) are derivative instruments under ASC 815, Derivatives and Hedging. The Omnitek option, which requires physical settlement, is accounted for as an equity security under ASC 321, Investments—Equity Securities, and is measured at fair value; the Company has not elected the measurement alternative. Investments are classified as current assets because the Company intends to exercise the Omnitek warrants and option within twelve months.
| 8 |
Deferred offering costs
Specific incremental costs directly attributable to a proposed offering of the Company’s securities are deferred and charged against the gross proceeds of the offering when it is completed. If an offering is abandoned or postponed for more than 90 days, the deferred costs are expensed.
Concentrations
All advisory fee revenue for the three months ended September 30, 2026 was earned from one customer, Omnitek Engineering Corp. (“Omnitek”), and all investments measured at fair value consist of Omnitek instruments. The value of those investments depends on the market price of Omnitek’s thinly traded common stock.
Fair value measurements
The Company applies ASC 820, Fair Value Measurement, which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes a hierarchy that prioritizes the inputs to valuation techniques:
| · | Level 1 – unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date; | |
| · | Level 2 – quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and other inputs that are observable, directly or indirectly; and | |
| · | Level 3 – unobservable inputs that are significant to the measurement and reflect the assumptions market participants would use in pricing the asset or liability. |
An asset or liability is categorized in its entirety based on the lowest level input that is significant to the measurement. The Company evaluates the volume and level of activity in the market for an instrument at each measurement date and does not apply a blockage factor. The Company recognizes transfers between levels as of the beginning of the reporting period in which the transfer occurs. The Company has not elected the fair value option under ASC 825 for any eligible financial asset or financial liability. See Note 5, Investments and fair value measurements, for the Company’s recurring fair value measurements.
Recently issued accounting pronouncements
Recently adopted
ASU 2024-04, Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments, became effective for the Company on July 1, 2026. Adoption had no effect on these condensed financial statements because the Company had no convertible debt instruments outstanding during the period.
Not yet adopted
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, as clarified by ASU 2025-01. The ASU requires disaggregated disclosure in the notes of specified categories of expense, including employee compensation, included in each relevant expense caption on the face of the statement of operations. It is effective for the Company’s annual period beginning July 1, 2027 and interim periods beginning July 1, 2028, with early adoption permitted.
| 9 |
In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which removes references to software development project stages and requires capitalization of internal-use software costs to begin when management has authorized and committed to funding the project and it is probable that the project will be completed and the software used as intended. The ASU is effective for the Company beginning July 1, 2028, with early adoption permitted, and may be applied prospectively, retrospectively or under a modified transition approach.
In September 2025, the FASB issued ASU 2025-07, Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606): Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration from a Customer in a Revenue Contract. The ASU clarifies that share-based noncash consideration from a customer in a revenue contract, such as the warrants and option the Company received from Omnitek, is accounted for under ASC 606 until the Company’s right to receive or retain the consideration becomes unconditional, and under other applicable guidance thereafter. It is effective for the Company beginning July 1, 2027, with early adoption permitted.
In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, which clarifies the form and content of interim financial statements and adds a principle requiring disclosure of events and changes since the end of the last annual reporting period that have a material effect on the entity. It is effective for the Company for interim periods beginning July 1, 2028, with early adoption permitted.
The Company is evaluating the effect of these ASUs on its financial statements and disclosures. Other recently issued accounting pronouncements are not expected to have a material effect on the Company’s financial statements.
Note 3 - Liquidity
As of September 30, 2026, the Company had cash
of $
Under at-will offer letters effective September
1, 2026 with four employees, salaries at an aggregate annual rate of $
Management evaluated whether conditions and events,
considered in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern within one year
after the date these condensed financial statements are issued. In making that evaluation, management considered the Company’s history
of recurring losses from operations, its accumulated deficit of $
The evaluation is based on a cash flow projection through the end of that one-year period that relies only on the Company’s existing cash. The projection reflects the Company’s recurring costs of maintaining its corporate existence and public reporting, estimated at $105,000 per quarter; ongoing discretionary spending of approximately $47,000 per quarter; payment of accounts payable outstanding as of September 30, 2026 other than costs of the potential acquisition; the cost of filing the Company’s delinquent income tax returns; and the fees payable under the tokenization agreement the Company entered into on November 2, 2026 (Note 16, Subsequent events). It excludes (i) costs of the potential acquisition, which the counterparty is obligated to repay if the acquisition is not completed and which management expects to fund at closing from the proceeds of financing required to complete the acquisition, and (ii) salaries, payroll taxes, and medical coverage, which begin only upon completion of additional fundraising and would be funded from its proceeds. Based on that evaluation, management concluded that conditions and events, considered in the aggregate, do not raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these condensed financial statements are issued.
If the Company were required to fund the costs of the potential acquisition from existing cash without reimbursement, if compensation became payable before additional capital is raised, or if costs significantly exceeded management’s estimates, the Company’s existing cash would not be sufficient to fund its obligations through the end of that period without additional financing or reductions in discretionary expenditures. The company will require additional capital to complete the potential acquisition and to execute its business strategy, and there can be no assurance that such capital will be available on acceptable terms, or at all.
| 10 |
Note 4 - Revenue
During the three months ended September 30, 2026,
the Company provided advisory services to Omnitek in connection with Omnitek’s acquisition of Hard Rock Ready Mix, LLC. The services
included structuring the capitalization table, procuring legal professionals, making introductions to parties to the transaction, advising
on the spin-out of Omnitek’s legacy business, and advising on SEC filing matters. The fee was not related to capital raised. Consideration
consisted of $
Revenue for the three months ended September 30, 2026 is disaggregated by type of consideration as follows:
| Schedule of disaggregation of revenue by type of consideration | ||||
| Amount | ||||
| Cash consideration | $ | |||
| Noncash consideration – Omnitek fee warrants ( | ||||
| Total advisory fee revenue | $ | |||
All revenue was recognized at a point in time and earned in the United States. As of September 30, 2026, the Company had no accounts receivable, contract assets or contract liabilities other than the right to receive the Omnitek fee warrants, which is included in investments at fair value (Note 5, Investments and fair value measurements). No revenue was recognized during the three months ended September 30, 2026 from performance obligations satisfied in prior periods.
As of September 30, 2026, the Company had no remaining unsatisfied performance obligations under the Omnitek engagement.
Note 5 - Investments and fair value measurements
Investments at fair value consist of instruments of Omnitek Engineering Corp. (OTC: OMTK):
| Schedule of fair value of investments | ||||||||||||||||
| Instrument | Shares underlying | Fair value at initial recognition | Unrealized gain | Fair value, September 30, 2026 | ||||||||||||
| Warrants purchased in September 2026 private placement (“Warrant 2026-01”) | ||||||||||||||||
| Fee warrants (“Warrant 2026-02”) | ||||||||||||||||
| Option | ( | ) | ||||||||||||||
| Total | $ | $ | $ | |||||||||||||
The $
| 11 |
The Company had the following assets measured
at fair value on a recurring basis as of September 30, 2026. There were
| Schedule of fair value of assets measured on a recurring basis | ||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Investments – Omnitek warrants and option | $ | – | $ | – | $ | $ | ||||||||||
Changes in Level 3 assets measured at fair value on a recurring basis for the three months ended September 30, 2026:
| Schedule of changes in level 3 assets measured at fair value on a recurring basis | ||||
| Amount | ||||
| Balance, June 30, 2026 | $ | – | ||
| Purchases | ||||
| Noncash consideration received | ||||
| Unrealized gain included in earnings | ||||
| Balance, September 30, 2026 | $ | |||
The Company estimates the fair value of the Omnitek warrants and option using the Black-Scholes option-pricing model. The Omnitek common stock price is an observable input; expected volatility, the expected term and the discount for lack of marketability are unobservable, so the measurements are categorized within Level 3. As of September 30, 2026, the Company used the $0.0299 closing price of Omnitek common stock on that date, when 1,265,665 shares traded in 101 trades following Omnitek’s Current Report on Form 8-K disclosing the transactions. At initial recognition of the option on September 29, 2026, the Company used $0.0299 September 30, 2026 closing price as an adjusted input. The last reported trade before that date $0.0121 on September 25, 2026, preceded the signing and public disclosure of the transactions, and ASC 820 requires a quoted price to be adjusted for significant events that occur after it. Warrant 2026-02, which Omnitek reported as issued to the Company on September 30, 2026 and which bears an issue date of October 1, 2026, has terms similar to Warrant 2026-01. Other inputs were exercise prices of $0.004 per share for the warrants and $0.01 per share for the option; expected terms equal to the remaining contractual terms (warrants expiring September 29, 2031 and October 1, 2031, and the option expiring March 31, 2027); and risk-free interest rates based on U.S. Treasury yields for comparable terms. The warrant shares and option shares are unregistered and may not be resold until the Rule 144 holding period has elapsed, which the Company estimates will occur on March 29, 2027 for Warrant 2026-01, April 1, 2027 for Warrant 2026-02 and approximately September 30, 2027 for shares acquired upon exercise of the option. The Company applied a discount for lack of marketability, estimated using the Finnerty average-strike put model over the period from the measurement date to the earliest resale date, to the Omnitek stock price. No discount was applied for the size of the Company’s holding, and the warrants and option are not subject to any contractual lock-up. The expected term used is the contractual term, consistent with market participant assumptions, rather than the Company’s expected exercise of the instruments within twelve months.
The following table presents quantitative information about the significant unobservable inputs used in the Level 3 measurements:
| Schedule of significant unobservable inputs used in level 3 measurements | |
| Significant unobservable input (Black-Scholes option-pricing model) | September 30, 2026 (September 29, 2026) |
| Expected volatility |
( |
| Discount for lack of marketability – warrants |
( |
| Discount for lack of marketability – option |
( |
| Period to earliest resale under Rule 144 – warrants (years) |
( |
| Period to earliest resale under Rule 144 – option (years) |
( |
| Expected term – warrants (years) |
( |
| Expected term – option (years) |
( |
| Risk-free interest rate – warrants |
( |
| Risk-free interest rate – option |
( |
| 12 |
The carrying amounts of cash, prepaid expenses, accounts payable and accrued liabilities approximate fair value because of their short maturities.
Note 6 - Equity method investment
The Company holds a
Note 7 - Prepaid expenses
| Schedule of prepaid expense | ||||||||
| September 30, 2026 | June 30, 2026 | |||||||
| Directors’ and officers’ liability insurance | $ | $ | ||||||
| Legal retainers | – | |||||||
| OTC Market fees | ||||||||
| Total prepaid expenses | $ | $ | ||||||
Note 8 - Advisory warrants and deferred offering costs
Advisory Agreement – warrants
On July 20, 2026, the Company entered into an Advisory Agreement with
a FINRA registered advisor (the “Advisor”) for advisory services related to M&A and capital-markets strategies.
As partial consideration, the Company sold the Advisor and fifteen of its designees warrants to purchase an aggregate of
The warrants were fully vested and
nonforfeitable at issuance. The Company measured them at their grant-date fair value of $
| 13 |
Deferred offering costs
On July 20, 2026, the Company separately entered
into an advisory agreement, under which the advisor is to act as exclusive placement agent for a proposed best-efforts private placement
of up to $20 million of the Company’s securities, and paid the advisor a $
Note 9 - Accounts payable, accrued liabilities
Accounts payable and accrued liabilities were
$
Note 10 - Related party transactions
The Company’s related parties are described in Note 8, Related party transactions, of the 2026 Form 10-K. Related party transactions entered into during the three months ended September 30, 2026 were as follows:
Executive compensation
On September 1, 2026, the Company entered into
at-will offer letters with David Wachsman, President, at an annual salary of $
Interests in controlling stockholder
David Wachsman, President, and Q. Byron Hamlett,
Chief Financial Officer, each hold a minority membership interest in HH, which owned approximately
Note 11 - Stockholders’ equity
Authorized capital
On August 20, 2026, the Amended and Restated Articles
of Incorporation became effective, increasing authorized common stock from
| 14 |
Common stock
Stock purchase warrants
Warrant activity for the three months ended September 30, 2026:
| Schedule of warrant activity | ||||||||||||
| Shares | Weighted-average exercise price | Remaining term (years) | ||||||||||
| Outstanding, June 30, 2026 | ||||||||||||
| Issued – advisory warrants (Note 8) | $ | |||||||||||
| Exercised / expired | ||||||||||||
| Outstanding and exercisable, September 30, 2026 | $ | |||||||||||
Stock options
Share-based compensation
The Company recognized share-based payment expense
of $
Investor relations consultant shares
On July 14, 2026, the Company entered into
an Investor Relations Agreement with an investor relations consultant with an initial term of six months that renews automatically
for successive six-month terms unless either party gives notice of non-renewal. As compensation, the Company pays the consultant
$10,000 per month and agreed to issue
| 15 |
Note 12 - Income taxes
The Company calculates its interim income tax
provision under ASC 740-270 by applying an estimated annual effective tax rate to year-to-date ordinary income and recognizing the tax
effect of discrete items in the period in which they occur. The Company recorded no provision for income taxes for the three months ended
September 30, 2026 and 2025. The estimated annual effective tax rate for fiscal 2027 is
As described in Note 12, Income taxes, of
the fiscal year 2026 Form 10-K, the change in control in fiscal year 2026 resulted in an ownership change under Section 382 of the
Internal Revenue Code, and the Company is completing an analysis to determine the resulting limitation on its pre-change net
operating loss carryforwards. The unrealized gain on investments and the noncash consideration received during the quarter create
taxable temporary differences. The Company has not filed its federal and state income tax returns for the tax year ended June 30,
2023 or any subsequent tax year.
Note 13 - Commitments and contingencies
Litigation
From time to time, the Company may be subject to claims arising in the ordinary course of business. The Company is not a party to any material pending legal proceeding and is not aware of any asserted or unasserted claims that management believes would have a material adverse effect on its financial position, results of operations or cash flows.
Employment arrangements
Under at-will offer letters effective September 1, 2026, salaries at an aggregate annual rate of $900,000 beginning the later of January 1, 2027 and the Company’s completion of additional fundraising, under the employees’ November 15, 2026 agreement to the deferral of the start of their compensation (Note 3, Liquidity); no compensation was accrued as of September 30, 2026. The offer letters are terminable at will, and employee medical coverage begins when salaries begin.
Potential recovery of acquisition costs
During the three months ended September 30,
2026, the Company advanced $
Indemnification
The Advisory Agreement contains customary indemnification of the Advisor and its affiliates. The Company has not accrued any indemnification liability.
| 16 |
Escrow deposit
As disclosed in the 2026 Form 10-K, the Company
had deposited $
Unfiled tax returns
See Note 12, Income taxes, regarding possible penalties and interest associated with delinquent income tax returns, the amount of which cannot be reasonably estimated.
Note 14 - Net loss per share
Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period, including shares issuable for little or no cash consideration are included from the date all necessary conditions are satisfied. Diluted net loss per common share includes the effect of potential common shares only when their inclusion is dilutive. Because the Company reported a net loss for the three months ended September 30, 2026 and 2025, potential common shares were excluded from diluted net loss per share because their effect would have been anti-dilutive.
The following table reconciles the numerator and denominator used in the basic and diluted net loss per common share calculations:
| Schedule of basic and diluted net loss per share | ||||||||
| Three Months Ended | ||||||||
| September 30, 2026 | September 30, 2025 | |||||||
| Net income (loss) | $ | ( | ) | $ | ( | ) | ||
| Weighted-average common shares outstanding – basic | ||||||||
| Effect of dilutive potential common shares | ||||||||
| Weighted-average common shares outstanding – diluted | ||||||||
| Net loss per share – basic and diluted | $ | ( | ) | $ | ( | ) | ||
The following potentially dilutive securities were excluded from the computation of diluted net loss per share because their effect would have been anti-dilutive:
| Schedule of antidilutive securities | ||||||||
| Three Months Ended | ||||||||
| September 30, 2026 | September 30, 2025 | |||||||
| Stock options (weighted-average exercise price $0.70 and $0.98, respectively) | ||||||||
| Stock to be issued – Rift intellectual property (as previously reported) | ||||||||
| Total potential dilutive securities excluded | ||||||||
The weighted-average common shares outstanding for the three months ended September 30, 2026 include, in addition to the 266,052,926 shares issued and outstanding, the 450,000 fully vested shares to be issued (200,000 shares to the government affairs consultant from July 1, 2026 and 250,000 shares to the investor relations consultant from July 14, 2026) and the 14,000,000 shares issuable upon exercise of the advisory warrants at an exercise price of $0.01 per share from their July 20, 2026 issuance date, which together added 11,523,370 weighted-average shares. These shares are not included in the shares issued and outstanding presented in the balance sheet.
In the Company’s financial statements for the year ended June 30, 2026, the 200,000 shares to be issued to the government affairs consultant were presented as potentially dilutive securities, and the shares issuable upon exercise of the HH Warrant ($0.01 exercise price) were included from its June 11, 2026 exercise date rather than its June 3, 2026 issuance date. Including those shares from the dates all necessary conditions were satisfied would not have changed the reported basic and diluted net loss per share of $(0.02) for fiscal year 2026. The weighted-average common shares outstanding for the three months ended September 30, 2025 are presented as previously reported and exclude the 500,000 shares to be issued for the Rift intellectual property; including them would not have changed the reported net loss per share of $(0.01).
| 17 |
Note 15 - Segment information
The Company has one
operating and reportable segment. The Company’s President is the chief operating decision maker (“CODM”). The CODM
assesses performance and decides how to allocate resources based on net loss as reported on the statements of operations, which
the CODM uses to monitor actual results against the Company’s budget and to make decisions about the pursuit of advisory
engagements, investments and acquisitions, and the hiring of personnel. Significant segment expenses regularly provided to the CODM
are presented below. The measure of segment assets is total assets as reported on the balance sheets, which were $
| Schedule of segment information | ||||||||
| Three Months Ended September 30, 2026 | Three Months Ended September 30, 2025 | |||||||
| Revenue | $ | $ | ||||||
| Less significant segment expenses: | ||||||||
| Professional fees | ||||||||
| Acquisition-related costs | ||||||||
| Sales and marketing | ||||||||
| General and administrative | ||||||||
| Other segment items (1) | ( | ) | ||||||
| Segment net loss | $ | ( | ) | $ | ( | ) | ||
_________________
| (1) |
Note 16 - Subsequent events
The Company evaluated subsequent events through November 16, 2026, the date these condensed financial statements were issued.
Director resignation
On October 29, 2026, Corby Marshall resigned from the Board of Directors. His resignation was not due to any disagreement with the Company.
Deferral of compensation
On November 15, 2026, the four employees agreed to the Company’s deferral of the start of their compensation until the later of January 1, 2027 and the Company’s completion of additional fundraising. Under the offer letters effective September 1, 2026, salaries at an aggregate annual rate of $900,000 were to begin upon completion of additional fundraising; no compensation was earned or accrued as of September 30, 2026 (Note 3, Liquidity).
| 18 |
Advisory warrants
In October 2026, the Advisor and its designees exercised all 14,000,000 warrants in full on a cashless basis. The Company issued an aggregate of 13,718,436 shares of common stock on October 13 and 14, 2026 upon those exercises, and the holders surrendered the right to purchase 281,564 warrant shares as the cashless exercise adjustment. The Company received no cash upon exercise, and no warrants remain outstanding.
Tokenization of stock
On November 2, 2026, the Company entered into a Tokenization Agreement with Securitize Transfer Agent, LLC (“Securitize”), under which Securitize will act as co-transfer agent, registrar and tokenization agent for the Company’s common stock alongside the Company’s existing transfer agent. Under the agreement, shares of the Company’s common stock may be issued, recorded and transferred as digital tokens on the Ethereum blockchain; the tokens represent shares of the Company’s existing common stock and do not create a new class of securities. The agreement has an initial term of twelve months, renews automatically for successive one-year terms unless either party gives notice of non-renewal, or may be terminated by the Company for convenience on 30 days’ notice. Fees include a $75,000 set-up fee payable upon execution of the agreement; a token issuance fee for each blockchain on which the common stock is deployed; a monthly servicing fee through December 31, 2027; and per-investor, per-event and blockchain transaction fees. The Company will recognize these fees as expense as the services are received.
| 19 |
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q, the other reports, statements, and information that we have previously filed or that we may subsequently file with the Securities and Exchange Commission (the “SEC”), and public announcements that we have previously made or may subsequently make include, may include, incorporate by reference or may incorporate by reference certain statements that may be deemed to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and are intended to enjoy the benefits of that act. Unless the context is otherwise, the forward-looking statements included or incorporated by reference in this Quarterly Report on Form 10-Q and those reports, statements, information and announcements address activities, events or developments that Hawkeye Digital, Inc. (hereinafter referred to as “we,” “us,” “our,” the “Company” or “Hawkeye”) expects or anticipates, will or may occur in the future. Any statements in this document about expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as “may,” “should,” “could,” “predict,” “potential,” “believe,” “will likely result,” “expect,” “will continue,” “anticipate,” “seek,” “estimate,” “intend,” “plan,” “projection,” “would” and “outlook,” and similar expressions. Accordingly, these statements involve estimates, assumptions, and uncertainties, which could cause actual results to differ materially from those expressed in them. All forward-looking statements concerning economic conditions, rates of growth, rates of income or values as may be included in this document are based on information available to us on the dates noted, and we assume no obligation to update any such forward-looking statements. It is important to note that our actual results may differ materially from those in such forward-looking statements due to fluctuations in interest rates, inflation, government regulations, economic conditions and competitive product and pricing pressures in the geographic and business areas in which we conduct operations, including our plans, objectives, expectations and intentions and other factors discussed elsewhere in this quarterly report.
Certain risk factors could materially and adversely affect our business, financial condition and results of operations and cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us, and you should not place undue reliance on any such forward-looking statements. These risks include those described under “Risk Factors” in Part II, Item 1A of this Quarterly Report on Form 10-Q and in Part I, Item 1A of our Annual Report on Form 10-K for the year ended June 30, 2026 (the “2026 Form 10-K”). Any forward-looking statement speaks only as of the date on which it is made, and we do not undertake any obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events, except as required by law. New factors emerge from time to time, and it is not possible for us to predict which will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
| 20 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the unaudited condensed financial statements and the notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q and with our audited financial statements and Management’s Discussion and Analysis for the year ended June 30, 2026 included in our 2026 Form 10-K. Some of the information contained in this discussion and analysis, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks, uncertainties and assumptions. You should read “Special Note Regarding Forward-Looking Statements” and “Risk Factors” in Part II, Item 1A of this Quarterly Report on Form 10-Q for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.
The following discussion relates to the historical operations and financial statements of Hawkeye Digital, Inc. for the three months ended September 30, 2026 and 2025.
Overview
From inception until July 2021, we focused on selling personal protective equipment. We underwent a change in control effective April 1, 2026, after which our strategy focuses on operating as a private equity and corporate advisory firm conducting merchant banking services in digital assets and other frontier verticals in financial services and technology. Our controlling stockholder, Hawkeye Holdco LLC (“HH”), owned approximately 87% of our outstanding common stock as of November 12, 2026. In connection with this realignment of our business strategy, we intend to raise capital to invest in and potentially acquire controlling interests in companies that fit our investment criteria (each, a “target business”), as well as recruit and retain additional personnel to provide companies with business advisory services. We are not registered as a broker-dealer and intend to conduct activities requiring registration only through appropriately registered entities.
We hold a 19.9% membership interest in Rift Cyber LLC (“Rift”), which is developing a unified smart sensor platform, Rythe, at the intersection of physical security and cybersecurity. Rift has not generated revenue, and we account for our interest under the equity method.
The three months ended September 30, 2026 were our first full quarter executing this strategy. Significant developments during the quarter included the following:
| · | First advisory engagement. We completed an advisory engagement for Omnitek Engineering Corp. (OTC: OMTK) (“Omnitek”) in connection with Omnitek’s acquisition of Hard Rock Ready Mix, LLC and recognized advisory fee revenue of $681,290, consisting of $300,000 in cash and $381,290 in Omnitek warrants measured at fair value. We also purchased Omnitek warrants for $550,000 in September 2026. | |
| · | Corporate actions. On August 20, 2026, our Amended and Restated Articles of Incorporation became effective, changing our name from Hawkeye Systems, Inc. to Hawkeye Digital, Inc., increasing our authorized common stock to 10,000,000,000 shares and classifying our Board of Directors. | |
| · | Employees. Effective September 1, 2026, we entered into at-will offer letters with four individuals, including our President and Chief Financial Officer, at an aggregate annual salary rate of $900,000. No compensation was accrued for the quarter. On November 15, 2026, the four employees agreed to our deferral of the start of their compensation until the later of January 1, 2027 and the Company’s completion of additional fundraising. |
| 21 |
| · | Potential acquisition. We are pursuing a potential business acquisition under a non-binding letter of intent and incurred $394,193 of legal, accounting, audit, quality-of-earnings and other costs in connection with it. Completion is subject to, among other things, our obtaining the financing necessary to complete it. |
Our financial results are, and we expect them to continue to be, primarily driven by:
| · | the number, size and timing of the advisory engagements we complete, which depend on the closing of client transactions; | |
| · | the form of the consideration we receive, including the portion paid in securities of our clients rather than in cash; | |
| · | changes in the fair value of client securities we hold, which are remeasured through earnings each quarter; | |
| · | the costs of pursuing acquisitions, including the potential acquisition described above, which we expense as incurred whether or not a transaction is completed; and | |
| · | compensation and other costs of building our team, and our ability to raise capital to fund our strategy. |
Results of Operations – Three Months Ended September 30, 2026 Compared with September 30, 2025
| 2026 | 2025 | $ Change | % Change | |||||||||||||
| Advisory fee revenue | $ | 681,290 | $ | – | $ | 681,290 | n/m | |||||||||
| Professional fees | 1,899,912 | 27,127 | 1,872,785 | 6,904% | ||||||||||||
| Acquisition-related costs | 394,193 | – | 394,193 | n/m | ||||||||||||
| Sales and marketing | 58,153 | – | 58,153 | n/m | ||||||||||||
| General and administrative | 100,805 | 6,380 | 94,425 | 1,480% | ||||||||||||
| Total operating expenses | 2,453,063 | 33,507 | 2,419,556 | 7,221% | ||||||||||||
| Loss from operations | (1,771,773 | ) | (33,507 | ) | (1,738,266 | ) | n/m | |||||||||
| Interest income | 11,283 | – | 11,283 | n/m | ||||||||||||
| Interest expense, including related party | (516 | ) | (68,026 | ) | 67,510 | 99% | ||||||||||
| Unrealized gain on investments | 1,614,095 | – | 1,614,095 | n/m | ||||||||||||
| Total other income (expense), net | 1,624,862 | (68,026 | ) | 1,692,888 | n/m | |||||||||||
| Provision for income taxes | – | – | – | – | ||||||||||||
| Net loss | $ | (146,911 | ) | $ | (101,533 | ) | $ | (45,378 | ) | n/m | ||||||
n/m – not meaningful.
Revenue
Advisory fee revenue of $681,290 for the three months ended September 30, 2026 was earned entirely from the Omnitek engagement (Note 4). We had no revenue in the prior-year quarter. Revenue comprised $300,000 of cash received on September 29, 2026 and $381,290 of noncash consideration: warrants to purchase 16,666,667 shares of Omnitek common stock, measured at fair value. Our advisory revenue depends on the completion of discrete transactions, is concentrated in a single client for the quarter, and is not expected to be consistent from quarter to quarter.
| 22 |
Operating expenses
Total operating expenses increased $2,419,556, to $2,453,063 from $33,507, as we began executing our strategy. The principal changes were:
| · | Acquisition-related costs of $394,193 consisted of legal, audit, quality-of-earnings and other professional fees incurred in connection with the potential business acquisition we are pursuing. These costs are expensed as incurred. The counterparty has agreed to reimburse transaction costs we have incurred if the acquisition is not completed; we will not recognize any reimbursement until our right to it is established. These costs include $110,000 of transaction costs we advanced during the quarter, which are subject to clawback under the letter of intent if the acquisition is not completed (Note 13, Commitments and contingencies). We expect to continue to incur such costs until the proposed transaction is completed or abandoned, and we do not expect them to recur thereafter. | |
| · | Professional fees increased $1,872,785, to $1,899,912 from $27,127, primarily because of the $1,662,084 grant-date fair value of the warrants issued to the Advisor and its designees in excess of the cash received, which we recognized as expense (Note 8), legal fees for corporate, securities and regulatory matters ($72,009), and accounting and audit fees ($93,125, principally the audit of our fiscal 2026 financial statements) and consulting fees for software development, reputation management and communications ($37,720), as we transitioned to an advisory business. | |
| · | General and administrative expense increased $94,425, to $100,805 from $6,380, primarily because of travel and related costs ($56,118, including meals) associated with business development, amortization of directors’ and officers’ liability insurance ($29,089) that we did not carry in the prior-year quarter, and public-company, OTC Markets and transfer agent costs ($9,409). | |
| · | Sales and marketing expense of $58,153 consisted primarily of investor relations consulting services ($45,598, comprising $10,000 of cash fees and $35,598 of noncash expense for 250,000 shares of common stock to be issued as compensation), LinkedIn recruiting and advertising, and conference attendance. |
Other income (expense), net
Other income, net, was $1,624,862, compared with other expense, net, of $68,026 in the prior-year quarter. The current quarter consisted principally of a $1,614,095 unrealized gain on the Omnitek warrants and option, comprising $62,058 recognized at initial recognition of the option and $1,552,037 from the remeasurement of the Omnitek instruments to fair value as of September 30, 2026, and $11,283 of interest income on money market balances. The prior-year quarter consisted of interest on the related-party promissory note, which was purchased by HH, exchanged and converted into common stock during the fourth quarter of fiscal 2026; we had no indebtedness during the current quarter. The unrealized gain depends on the market price of Omnitek’s thinly traded common stock and on significant unobservable inputs, and it may reverse in future periods.
Income taxes
We recorded no provision for income taxes for either period, and our effective tax rate was 0% for both periods. Our estimated annual effective tax rate for fiscal 2027 reflects the expected change in the valuation allowance on our deferred tax assets, which remain subject to the Section 382 limitation arising from our change in control (Note 12, Income taxes).
Net loss
We reported a net loss of $146,911, or $(0.00) per basic and diluted share, compared with a net loss of $101,533, or $(0.01) per share, in the prior-year quarter. Our results for the quarter were driven largely by noncash items: noncash advisory revenue of $381,290 and the unrealized gain on investments of $1,614,095 together contributed $1,995,385 to our results, more than offset by $1,697,682 of noncash share-based payment expense, and net cash used in operating activities was $354,882 (see “Liquidity and Capital Resources”). Weighted-average shares outstanding increased to 277,576,296 from 8,706,772, principally because of the 255,017,296 shares issued in June 2026 in connection with our change in control.
| 23 |
Non-GAAP Financial Measure – Adjusted EBITDA
In addition to our results determined in accordance with U.S. GAAP, we use Adjusted EBITDA, a non-GAAP financial measure, to evaluate the performance of our advisory operations. EBITDA and Adjusted EBITDA are not measurements of our financial performance under U.S. GAAP and EBITDA and Adjusted EBITDA have limitations as an analytical tool and should not be considered in isolation or as a substitute for net loss or other measures prepared in accordance with U.S. GAAP. We define Adjusted EBITDA as net loss before interest expense, interest income, provision for income taxes and depreciation and amortization (“EBITDA”), further adjusted to exclude share-based payment expense, unrealized gains and losses on our investments in client securities, and acquisition-related costs. We believe Adjusted EBITDA is useful to investors because it excludes items that can vary significantly from period to period for reasons unrelated to the performance of our advisory operations:
| · | Share-based payments. We exclude the expense for equity instruments issued for services, consisting of the warrants issued under our Advisory Agreement ($1,662,084) and the shares to be issued to investor relations consultant ($35,598). The expense is noncash, is measured using our stock price and Level 3 valuation inputs at the grant date, and varies with the timing, size and nature of awards. | |
| · | Unrealized gains and losses on investments. We exclude changes in the fair value of the Omnitek warrants and option after initial recognition. These gains are noncash, depend on the price of Omnitek’s thinly traded common stock, and may reverse before the instruments are exercised and the underlying shares are sold. | |
| · | Acquisition-related costs. We exclude legal, audit, quality-of-earnings and other costs of the potential business acquisition we are pursuing, which we do not consider costs of operating our advisory business and which are subject to clawback or reimbursement if the acquisition is not completed (Note 13 to the condensed financial statements). |
We caution investors that amounts presented in accordance with our definitions of Adjusted EBITDA may not be comparable to similar measures disclosed by our competitors, because not all companies and analysts calculate the Adjusted EBITDA in the same manner. We present the EBITDA and Adjusted EBITDA because we consider them to be important supplemental measures of our performance and believe they are frequently used by securities analysts, investors, and other interested parties in the evaluation of companies in our industry. Management believes that investors’ understanding of our performance is enhanced by including EBITDA and Adjusted EBITDA as a reasonable basis for comparing our ongoing results of operations.
Management uses EBITDA and Adjusted EBITDA:
| · | as measurements of operating performance because they assist us in comparing the operating performance of our business on a consistent basis, as they remove the impact of items not directly resulting from our core operations; | |
| · | for planning purposes, including the preparation of our internal annual operating budget and financial projections; | |
| · | to evaluate the performance and effectiveness of our operational strategies; and | |
| · | to evaluate our capacity to expand our business. |
By providing these Non-GAAP Financial Measures, together with reconciliations, we believe we are enhancing investors’ understanding of our business and our results of operations, as well as assisting investors in evaluating how well we are executing our strategic initiatives.
| 24 |
Some of the limitations are:
| · | such measures do not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments; | |
| · | such measures do not reflect changes in, or cash requirements for, our working capital needs; | |
| · | Such measures do not reflect the interest expense, or the cash requirements necessary to service interest or principal payments on our debt; | |
| · | although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future and such measures do not reflect any cash requirements for such replacements; | |
| · | certain of the items excluded in arriving at such measures require settlement in cash, and excluding an item does not reduce the cash we are required to pay in respect of that item; and | |
| · | other companies in our industry may calculate such measures differently than we do, limiting their usefulness as comparative measures. |
Due to these limitations, these non-GAAP financial measures should not be considered as measures of discretionary cash available to us to invest in the growth of our business. We compensate for these limitations by relying primarily on our U.S. GAAP results and using these non-GAAP measures only as a supplement. As noted in the tables below, these non-GAAP financial measures include adjustments for non-cash charges related to share based compensation, unrealized gain on investments and acquisition related costs. It is reasonable to expect that certain of these items will occur in future periods. However, we believe these adjustments are appropriate because the amounts recognized can vary significantly from period to period, do not directly relate to the ongoing operations of our business and complicate comparisons of our internal operating results and operating results of other companies over time. Each of the adjustments described herein and in the reconciliation tables below help management with a measure of our core operating performance over time by removing items that are not related to day-to-day operations.
Adjusted EBITDA does not adjust our revenue: it includes $381,290 of advisory revenue we received in the form of Omnitek securities, which has not been converted to cash and whose realizable value depends on the Omnitek stock price. Adjusted EBITDA also does not reflect the cash we paid for acquisition-related costs or our cash requirements for working capital.
The following table reconciles net loss, the most directly comparable GAAP measure, to Adjusted EBITDA:
| Three Months Ended | ||||||||
| September 30, 2026 | September 30, 2025 | |||||||
| Net loss (GAAP) | $ | (146,911 | ) | $ | (101,533 | ) | ||
| Interest expense, including related party | 516 | 68,026 | ||||||
| Interest income | (11,283 | ) | – | |||||
| Provision for income taxes | – | – | ||||||
| Depreciation and amortization | – | – | ||||||
| EBITDA (non-GAAP) | (157,678 | ) | (33,507 | ) | ||||
| Share-based payments (Notes 8 and 11) | 1,697,682 | – | ||||||
| Unrealized gain on investments in Omnitek securities (Note 5) | (1,614,095 | ) | – | |||||
| Acquisition-related costs | 394,193 | – | ||||||
| Adjusted EBITDA (non-GAAP) | $ | 320,102 | $ | (33,507 | ) | |||
Adjusted EBITDA was $320,102 for the three months ended September 30, 2026, compared with $(33,507) for the prior-year quarter, while our net loss was $146,911 and $101,533, respectively. The change reflects the $681,290 of advisory revenue from our first engagement, of which $381,290 was received in the form of Omnitek securities, partially offset by higher professional, general and administrative and sales and marketing expenses as we began executing our strategy. In the prior-year quarter, the only adjustment was interest expense on a related-party note. Net cash used in operating activities was $354,882 in the current quarter (see “Liquidity and Capital Resources”).
| 25 |
Financial Condition
| September 30, 2026 | June 30, 2026 | $ Change | % Change | |||||||||||||
| Cash | $ | 1,190,461 | $ | 2,105,343 | $ | (914,882 | ) | (43 | )% | |||||||
| Prepaid expenses | 118,770 | 119,027 | (257 | ) | (0 | )% | ||||||||||
| Investments, at fair value | 2,545,385 | – | 2,545,385 | n/m | ||||||||||||
| Equity method investment – Rift | 39,800 | 39,800 | – | n/m | ||||||||||||
| Deferred offering costs | 150,000 | – | 150,000 | n/m | ||||||||||||
| Total assets | 4,044,416 | 2,264,170 | 1,780,246 | 79% | ||||||||||||
| Total current liabilities | 362,257 | 272,782 | 89,475 | 33% | ||||||||||||
| Working capital, excluding Omnitek investments, deferred offering costs | 946,974 | 1,951,588 | (1,004,614 | ) | (51 | )% | ||||||||||
| Total stockholders’ equity | $ | 3,682,159 | $ | 1,991,388 | $ | 1,690,771 | 85% | |||||||||
n/m – not meaningful.
Total assets increased $1,780,246 during the quarter, principally because of the Omnitek warrants and option, which are carried at a fair value of $2,545,385, and the $150,000 engagement fee paid to the Advisor, recorded as deferred offering costs, partially offset by the $914,882 decrease in cash. Total stockholders’ equity increased $1,690,771, reflecting the $1,802,084 grant-date fair value of the advisory warrants recorded in additional paid-in capital and the $35,598 grant-date fair value of common stock to be issued, partially offset by our net loss of $146,911. As of September 30, 2026, approximately 63% of our total assets consisted of the Omnitek instruments and approximately 4% consisted of deferred offering costs; neither is a source of near-term liquidity.
Liquidity and Capital Resources
As of September 30, 2026, we had cash of $1,190,461, compared with $2,105,343 as of June 30, 2026. We had working capital of $3,642,359, or $946,974 excluding $2,545,385 of Omnitek investments, which are restricted and not readily convertible into cash, and $150,000 of deferred offering costs, which will not be realized in cash, no outstanding indebtedness and total liabilities of $362,257, consisting of accounts payable and accrued liabilities of $362,257. We also held Omnitek warrants and an option with an estimated fair value of $2,545,385. These instruments are not traded on an exchange, may be subject to transfer restrictions, and any sale of the underlying Omnitek shares would depend on the limited trading volume in Omnitek’s common stock. We may not be able to convert them into cash at their carrying value, or at all, and we have not included them in our assessment of the cash available to fund our operations.
| Cash flows for the three months ended September 30, | 2026 | 2025 | ||||||
| Net cash used in operating activities | $ | (354,882 | ) | $ | (59,611 | ) | ||
| Net cash used in investing activities | (550,000 | ) | (10,000 | ) | ||||
| Net cash provided by (used in) financing activities | (10,000 | ) | 69,427 | |||||
| Net change in cash | $ | (914,882 | ) | $ | (184 | ) | ||
Operating activities
Net cash used in operating activities was $354,882, compared with $59,611 in the prior-year quarter. Our net loss of $146,911 included $1,697,682 of noncash share-based payment expense and $1,995,385 of noncash revenue and unrealized gains. Prepaid expenses were substantially unchanged, as new legal retainers and prepaid fees were offset by amortization of prepaid directors’ and officers’ liability insurance. These uses were partially offset by an increase of $89,475 in accounts payable and accrued liabilities. During the first quarter, cash used in operating activities included approximately $112,650 of costs paid in connection with the potential acquisition, none of which we expect to recur.
| 26 |
Investing activities
Cash used in investing activities was $550,000, reflecting our purchase of Omnitek warrants in Omnitek’s September 2026 private placement. These were the funds previously held in escrow, as disclosed in our 2026 Form 10-K. In the prior-year quarter, we used $10,000 for third-party development costs associated with Rift technology, which were capitalized into our investment in Rift at that time and expensed in fiscal 2026.
Financing activities
Net cash used in financing activities was $10,000: we received $140,000 from the sale of warrants to the Advisor and its designees under our Advisory Agreement and, separately, paid the Advisor a $150,000 non-refundable engagement fee under our private placement agreement, which we recorded as a deferred offering cost. In October 2026, all 14,000,000 warrants were exercised on a cashless basis, and we received no cash upon exercise. In the prior-year quarter, financing activities consisted of $69,427 of advances under a related-party promissory note, which arrangement no longer exists.
During the three months ended September 30, 2026 and 2025, we received $0 and $69,427, respectively, from related parties.
Plan of Operation and Funding
Executing our business strategy at the scale we contemplate — including completing the potential acquisition we are pursuing, exploring the acquisition of a FINRA-registered broker-dealer, recruiting and retaining investment and advisory personnel, and any further investment in Rift — will require capital in excess of our existing resources. Most of those initiatives are discretionary and within management’s control to defer. We expect to fund them through a combination of existing cash, cash advisory fees, the monetization of securities received as fees, and the sale of equity or debt securities. Separately from our Advisory Agreement, we have engaged an advisor in connection with proposed offerings of our securities. The size, pricing, nature and timing of any offering have not been determined and will depend on market conditions and other factors. There can be no assurance that either offering will be completed. We have no lines of credit or other bank financing arrangements, and no commitment from any party to provide additional financing.
Additional issuances of equity or convertible debt securities will result in dilution to our current stockholders, and that dilution could be substantial. Our authorized common stock is 10,000,000,000 shares, and we may issue a significant number of additional shares without further stockholder approval. Securities issued in future financings might have rights, preferences, or privileges senior to our common stock. Additional financing may not be available on acceptable terms, or at all.
| 27 |
Future Capital Requirements
We anticipate that our future capital requirements will principally consist of funds required for:
| · | operating, public-company and general corporate expenses, including legal, accounting and audit fees; | |
| · | salaries, at an aggregate annual rate of $900,000, together with employee medical coverage beginning the later of January 1, 2027 and the Company’s completion of additional fundraising, and in addition to any additional employees that we may hire in connection with expanding our merchant banking business; | |
| · | costs of the potential acquisition we are pursuing (to the extent not reimbursed or funded at closing), including legal, audit and quality-of-earnings fees, and any cash consideration payable if the acquisition is completed; | |
| · | the potential acquisition and operation of a FINRA-registered broker-dealer or other businesses; | |
| · | investments in securities of our clients, such as our $550,000 purchase of Omnitek warrants during the quarter, and any further investment in Rift; and | |
| · | fees payable to advisors in connection with any future offering of our securities. |
Uncertainties and Trends Affecting Liquidity
Our assessment of our liquidity does not take into account events beyond our control, the completion of any acquisition, or other unanticipated uses of cash, any of which could require us to raise additional capital sooner than we expect. Our ability to raise additional capital, if necessary, is subject to a variety of factors that we cannot predict with certainty, including:
| · | the market price and trading volume of our common stock, which is quoted on the OTCID Basic Market; | |
| · | the market price of Omnitek’s common stock and our ability to sell the Omnitek securities we hold; | |
| · | our ability to secure advisory engagements that pay fees in cash; | |
| · | the volatility and overall condition of the capital markets; and | |
| · | the willingness of our controlling stockholder and other investors to provide financing. |
Liquidity Outlook
Management has evaluated whether conditions and events, considered in the aggregate, raise substantial doubt about our ability to continue as a going concern within one year after the date the condensed financial statements included in this report are issued (Note 3, Liquidity). The evaluation relies on our existing cash alone. Our cash flow projection through that date includes our recurring costs of maintaining our corporate existence and public reporting of approximately $105,000 per quarter, ongoing discretionary business development spending of approximately $47,000 per quarter, payment of accounts payable outstanding as of September 30, 2026 other than costs of the potential acquisition, the cost of filing our delinquent income tax returns, and the fees under our November 2, 2026 tokenization agreement. It assumes no future advisory fees, no proceeds from any financing and no sale of the Omnitek securities. It excludes the costs of the potential acquisition, which the counterparty is obligated to repay if the acquisition is not completed and which we expect to fund at closing from the proceeds of the financing required to complete it. It also excludes salaries, payroll taxes, and medical coverage, which begin on the later of January 1, 2027 and the Company’s completion of additional fundraising and would be funded from its proceeds. On that basis, we expect our existing cash to be sufficient to meet our obligations as they become due through that date, with approximately $243,000 remaining, and our monthly costs could exceed the projection by approximately 50% before our cash would be exhausted within that period. Management therefore concluded that conditions and events, considered in the aggregate, do not raise substantial doubt about our ability to continue as a going concern.
That conclusion depends on two judgements: that we will not pay the costs of the potential acquisition from existing cash within that period, and that compensation will not become payable before we raise additional capital. If we were required to fund those acquisition costs, which we estimate at approximately $457,000 including costs to closing and post-closing reporting costs, or if compensation became payable before we raise capital, our existing cash would not be sufficient through that date, and we would need to reduce discretionary expenditures or obtain additional financing sooner than we expect. We nevertheless expect to require additional capital to complete the potential acquisition and to execute our business strategy at the scale we contemplate.
| 28 |
Material Commitments
As of September 30, 2026, we had no debt obligations, no capital commitments and no material contractual commitments other than (i) the at-will offer letters described above, under which salaries at an aggregate annual rate of $900,000 beginning the later of January 1, 2027 and the Company’s completion of additional fundraising, as deferred by the employees on November 15, 2026, (ii) our Advisory Agreement, which contains customary indemnification provisions, and (iii) our Investor Relations Agreement, under which we pay $10,000 per month through its initial term ending in January 2027, after which it renews automatically for six-month terms unless either party gives notice, payments held as of October 1, 2026 until uplisting. On November 2, 2026, we entered into a Tokenization Agreement with Securitize Transfer Agent, LLC, under which we will pay a $75,000 set-up fee, token issuance and monthly servicing fees, as described in Note 16 to the condensed financial statements. We have also entered into a non-binding letter of intent for a potential business acquisition, and engagement letters with legal and accounting advisors for that transaction; $231,542 of costs incurred under those engagements was included in accounts payable as of September 30, 2026. We were not a party to any material pending legal proceeding.
Purchase of Significant Equipment
We do not intend to purchase any significant equipment during the next twelve months.
Off-Balance Sheet Arrangements
As of September 30, 2026, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.
Known Trends and Uncertainties
| · | Our reported results will fluctuate with the market price of Omnitek’s common stock, because the Omnitek instruments are remeasured at fair value through earnings each quarter. A decline in that price would result in unrealized losses that could exceed the gains recognized in the current quarter. | |
| · | Most of the consideration from our first engagement was paid in securities. As of September 30, 2026, investment securities, consisting of the Omnitek instruments and our interest in Rift, represented approximately 91% of our total assets excluding cash, which exceeds the 40% threshold in Section 3(a)(1)(C) of the Investment Company Act of 1940. If a significant portion of our assets continues to consist of investment securities, we could be deemed an investment company under that Act unless an exclusion or exemption is available. | |
| · | We are pursuing a potential business acquisition under a non-binding letter of intent. We expect to continue to incur significant costs until it is completed or abandoned, and completing it will require financing that we have not yet obtained. If it is not completed, recovery of our costs will depend on the counterparty’s reimbursement. | |
| · | The deferred offering costs of $150,000 will be charged to expense if the related offering is abandoned or postponed for more than 90 days. | |
| · | Salaries of approximately $900,000 per year will begin the later of January 1, 2027 and the Company’s completion of additional fundraising, which will reduce the net proceeds available to fund our strategy. |
| 29 |
Critical Accounting Policies and Estimates
Our accounting and reporting policies comply with U.S. GAAP. The preparation of financial statements in compliance with U.S. GAAP requires us to make estimates and assumptions that could materially affect amounts reported in our financial statements. Critical accounting estimates are those that we believe are the most important to the portrayal of our financial condition and results of operations and that require us to make estimates that are difficult, subjective or complex. Our critical accounting estimates are described in our 2026 Form 10-K. During the quarter ended September 30, 2026, the following estimates became critical as a result of new transactions. We are generally unable to validate these estimates against independent third-party sources.
Revenue from noncash consideration
We measure noncash consideration received for advisory services, including warrants and options to acquire a client’s equity securities, at fair value at contract inception. Of our $681,290 of revenue for the quarter, $381,290 was noncash consideration in the form of the Omnitek fee warrants. Determining the amount of revenue required us to estimate the fair value of instruments that are not traded and to determine which of the instruments we received were consideration for our services. We recognized the warrants we purchased in Omnitek’s private placement at their $550,000 purchase price at initial recognition. Changes in the fair value of noncash consideration after contract inception are recognized in other income (expense), not revenue.
Fair value of investments
We measure the Omnitek warrants and option at fair value each reporting date using a Black-Scholes option-pricing model with Level 3 inputs, principally expected volatility and a discount for lack of marketability of 20.2% to 26.1% that reflects the restrictions on resale of the underlying shares under Rule 144. The measurements determined both the noncash revenue recognized at contract inception and the $1,614,095 unrealized gain recognized as of September 30, 2026. A 10% increase or decrease in the Omnitek stock price as of September 30, 2026 would have increased or decreased the fair value of these instruments by approximately $264,000. Because the warrants are deep in the money, changes in expected volatility have a much smaller effect. A 5-percentage-point change in the discount for lack of marketability would have changed their fair value by approximately $166,000.
The Black-Scholes model assumes continuous trading and a lognormal distribution of returns, which may not describe a stock that trades as infrequently as Omnitek’s, and both our September 29, 2026 initial measurements and our September 30, 2026 measurement rely on a closing price set on the day Omnitek announced the transactions. We therefore considered alternative inputs and approaches. Using Omnitek’s $0.025 volume-weighted average price on September 30, 2026 instead of its $0.0299 closing price would have reduced the fair value of the warrants by approximately $417,000. Using an expected term of one year, reflecting our intention to exercise within twelve months, instead of the contractual term would have reduced it by approximately $260,000; we used the contractual term because fair value reflects the assumptions of market participants rather than our own plans. We did not use the $0.002 per share implied by the price of Omnitek’s Series A preferred stock issued in the transactions, because that negotiated price for a newly designed preferred security issued to Omnitek’s incoming control party is not a quoted price for its common stock; at that price, Warrant 2026-01 would have been valued at approximately $121,000 at initial recognition, less than the $550,000 we paid. The warrants would generate cash only upon exercise and sale of the underlying shares, which will depend on the trading volume and price of Omnitek’s common stock and on the 4.99% beneficial ownership limitation in the warrants.
Advisory warrants
We estimated the grant-date fair value of the 14,000,000 warrants issued to an advisor and its designees at $1,802,084 ($0.1287 per warrant), using a Black-Scholes option-pricing model with a share price equal to the 30-day volume-weighted average price of our common stock reduced by a 50% discount for lack of marketability. We also concluded that the warrants were issued solely as consideration under our Advisory Agreement and are not costs of an offering, so the $1,662,084 excess of fair value over the cash received was expensed as professional fees. We measured the 250,000 shares of common stock to be issued to investor relations consultant at $35,598 ($0.1424 per share).
| 30 |
Valuation of our equity method investment
Rift is a private entity that holds the intellectual property rights to Rythe technology and has generated no revenue since its formation. Determining the carrying amount of our investment requires us to estimate our share of Rift’s results and to assess whether any decline in value is other than temporary, based on information obtained from an investee we do not control. The carrying amount was $39,800 as of September 30, 2026.
Income taxes
Our estimated annual effective tax rate depends on our forecast of fiscal 2027 income, the outcome of our Section 382 analysis, the effect of any cancellation of indebtedness income on our tax attributes, and our assessment of the realizability of deferred tax assets, including whether taxable temporary differences arising from unrealized gains and noncash consideration can be offset by existing deferred tax assets.
Recently Issued Accounting Pronouncements
See Note 2, Summary of significant accounting policies, to the condensed financial statements for a discussion of recently issued accounting pronouncements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Not applicable. As a smaller reporting company, we are not required to provide the information required by this Item.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.
Our management, consisting of David Wachsman, President (principal executive officer), and Q. Byron Hamlett, Chief Financial Officer (principal financial and accounting officer), evaluated the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of September 30, 2026. Based on that evaluation, our management concluded that, as of September 30, 2026, our disclosure controls and procedures were not effective in recording, processing, summarizing and reporting on a timely basis information required to be disclosed in the reports that we file or submit under the Exchange Act, and were not effective in assuring that information required to be disclosed in those reports is accumulated and communicated to management to allow timely decisions regarding required disclosure. This conclusion is due to the material weaknesses in our internal control over financial reporting described in Item 9A of our 2026 Form 10-K, which had not been remediated as of September 30, 2026: (i) only two officers handling all financial transactions; (ii) a lack of appropriate operational controls and of consistency in providing our accounting personnel with financial information; (iii) incomplete financial statements on a daily basis and resulting errors in our underlying accounting system; (iv) a lack of proper documentation of our assessment and evaluation; and (v) limited segregation of duties because of our limited management structure.
| 31 |
The volume and complexity of the transactions we entered into during the quarter — including noncash consideration received in the form of warrants and options, the issuance of equity-classified warrants for services, and related-party transactions — increased the risk associated with these material weaknesses.
Notwithstanding these material weaknesses, management believes that the condensed financial statements included in this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP.
Remediation Plan
To respond to these material weaknesses, we have devoted, and plan to continue to devote, significant effort and resources to the remediation and improvement of our internal control over financial reporting. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will have the intended effects or that additional material weaknesses will not arise in the future.
Inherent Limitations on Effectiveness of Controls
Because of its inherent limitations, which include a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures, internal control over financial reporting may not prevent or detect misstatements, whether unintentional errors or fraud. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
| 32 |
PART II—OTHER INFORMATION
Item 1. Legal Proceedings.
From time to time, we may be named in claims arising in the ordinary course of business. Currently, we are not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this Quarterly Report on Form 10-Q, no director, officer, or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. We are not aware of any other legal proceedings pending or that have been threatened against us or our property that, in the opinion of management, could reasonably be expected to have a material adverse effect on our business and financial condition.
Item 1A. Risk Factors.
Careful consideration should be given to the following risk factors, together with all other information set forth in this Quarterly Report on Form 10-Q, including our condensed financial statements and related notes, and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and in other documents that we file with the SEC, in evaluating Hawkeye Digital, Inc. (the “Company”, “we”, or “our”) and our business, before investing in our common stock. Investing in our common stock involves a high degree of risk. If any of the following risks and uncertainties actually occur, our business, prospects, financial condition and results of operations could be materially and adversely affected. The market price of our common stock could decline if one or more of these risks or uncertainties were to occur, which may cause you to lose all or part of the money you paid to buy our common stock. The risk factors described below disclose both material and other risks and are not intended to be exhaustive and are not the only risks facing us. New risk factors can emerge from time to time, and it is not possible to predict the impact that any factor or combination of factors may have on our business, prospects, financial condition and results of operations. Certain statements below are forward-looking statements. See “Special Note Regarding Forward-Looking Statements” in this Quarterly Report on Form 10-Q.
The risk factors below update and supplements the risk factors disclosed in Part I, Item 1A of our 2026 Form 10-K. Risk factors that are new or have been materially updated since the 2026 Annual Report on Form 10-K include those relating to our concentration in Omnitek securities, the receipt of securities as fees, our pursuit of a potential business acquisition, our salary commitments, significant accounting judgments, and our status under the Investment Company Act of 1940.
Risks Related to Our Business
A significant portion of our assets consists of warrants and an option to acquire the securities of a single, thinly traded issuer, and the value of those instruments may decline significantly or may not be realizable.
As of September 30, 2026, we held warrants and an option to acquire Omnitek common stock with an estimated fair value of $2,545,385, representing approximately 63% of our total assets. Omnitek’s common stock is quoted on the OTC market and is thinly traded. The instruments are not traded on any market, may be subject to contractual and securities-law transfer restrictions, and their fair value is estimated using a valuation model with significant unobservable inputs, including expected volatility. Because we remeasure these instruments at fair value through earnings each quarter, a decline in the market price of Omnitek’s common stock, or a change in our valuation inputs, would result in unrealized losses that could be significant relative to our results of operations. We recognized an unrealized gain of $1,614,095 on these instruments in the quarter ended September 30, 2026, without which our net loss for the quarter would have been substantially larger, and that gain may reverse.
Even if the instruments retain their estimated value, we may be unable to convert them into cash. Exercising the warrants or option may require us to pay the exercise price in cash, and any sale of the underlying shares would depend on the limited trading volume in Omnitek’s common stock and on the availability of an exemption from registration. A sale of a significant number of Omnitek shares could depress the market price of those shares. Accordingly, the carrying value of these instruments should not be viewed as a source of near-term liquidity.
| 33 |
We have accepted, and may continue to accept, securities of our clients as payment for our services, which exposes us to market, liquidity and regulatory risks.
Most of the consideration for our first advisory engagement was paid in securities of the client rather than in cash, and we expect that future engagements with early-stage and growth companies may also be paid, in whole or in part, in equity securities, warrants or other instruments. Securities received as fees may be illiquid, may decline in value before we are able to sell them, and expose us to the business and market risks of our clients. Receiving transaction-related compensation in securities may also be a factor in determining whether particular activities require broker-dealer registration, and accumulating investment securities may affect our status under the Investment Company Act of 1940, as described below. In addition, measuring securities received as fees requires significant judgment, and changes in their value will cause our reported results to fluctuate.
Our business depends on a small number of individuals whose services are provided under at-will arrangements.
Our strategy depends on the reputations, relationships and experience of our executive officers and directors. Effective September 1, 2026, our President and Chief Financial Officer became employees under at-will offer letters that may be terminated by either party at any time, and their salaries begin the later of January 1, 2027 and the Company’s completion of additional fundraising. We do not have non-competition agreements with our executive officers and do not maintain key-person life insurance. The loss of any of these individuals, or a change in the arrangements under which they provide services, would materially impair our ability to source and execute transactions.
We are pursuing a potential business acquisition that we may not complete, and we will incur significant costs whether or not it is completed.
We have entered into a non-binding letter of intent for a potential business acquisition. During the quarter ended September 30, 2026, we incurred $394,193 of legal, accounting, audit, quality-of-earnings and other costs in connection with the potential acquisition, and we expect to continue to incur significant costs until it is completed or abandoned. Completion is subject to, among other things, negotiation and execution of definitive agreements, satisfactory completion of due diligence, approval by our Board of Directors and our ability to obtain the financing necessary to complete it. There can be no assurance that we will complete the acquisition on acceptable terms or at all, or that any acquired business will perform as expected. Although the counterparty has agreed to reimburse transaction costs we have incurred if the acquisition is not completed, we may not recover those costs in full or on a timely basis, and we may be required to pay them before any reimbursement is received.
Salaries will increase our cash requirements and reduce the resources available to fund our strategy.
Under at-will offer letters with four employees effective September 1, 2026, salaries at an aggregate annual rate of $900,000 were to begin, and no compensation was accrued as of September 30, 2026. On November 15, 2026, the employees agreed to our deferral of the start of their compensation until the later of January 1, 2027 and the Company’s completion of additional fundraising. Once salaries begin, they will cost approximately $245,000 per quarter, including payroll taxes, at current staffing, which will reduce the resources available to execute our strategy. Employee medical coverage will begin when salaries begin.
Our financial statements reflect significant accounting judgments regarding complex transactions, and changes in those judgments could materially affect our reported results.
During the quarter ended September 30, 2026, we entered into transactions that required significant accounting judgments, including (i) the measurement of noncash consideration received for advisory services and the determination that the excess of the fair value of warrants we purchased over their purchase price, and the option, were not consideration for our services and were recognized in unrealized gain on investments, (ii) the measurement of the Omnitek warrants and option using Level 3 inputs, (iii) the measurement of the grant-date fair value of the advisory warrants, including the discount for lack of marketability, and the determination that the $1,662,084 excess over the cash received should be expensed as a cost of the Advisory Agreement rather than deferred as an offering cost, and (iv) the estimation of our annual effective tax rate in light of our Section 382 limitation and delinquent tax returns. If these judgments are changed as a result of further analysis, the review of our independent registered public accounting firm, or comments from the SEC staff, we could be required to revise our financial statements, and the effect could be material. For example, each 10-percentage-point change in the discount for lack of marketability applied to the advisory warrants would have changed our net loss for the quarter by approximately $385,000.
| 34 |
You will be unable to ascertain the merits or risks of any particular future acquisition.
Although we intend to focus on conducting private equity business and conducting merchant banking services in digital assets and other frontier verticals in finance and technology, our efforts to identify potential strategic partners will not necessarily be limited to a particular industry, sector or geographic region. To the extent we complete future acquisitions, we may be affected by numerous risks inherent in the business operations with which we combine. For example, if we acquire or make an investment in a financially unstable business or an entity lacking an established record of sales or earnings, we may be affected by the risks inherent in the business and operations of a financially unstable or a development stage entity. There are no assurances that any target business with which we consummate an acquisition will perform as anticipated. Although our officers and directors will endeavor to evaluate the risks inherent in a particular business, we cannot assure you that we will properly ascertain or assess all of the significant risk factors or that we will have adequate time to complete due diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those risks will adversely impact a business.
If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our future acquisitions.
If we are deemed to be an investment company under the Investment Company Act, we may have to change our operations, wind down our operations, or register as an investment company under the Investment Company Act. Our activities may be restricted, including:
| · | restrictions on the nature of our investments; and | |
| · | restrictions on the issuance of securities, each of which may make it difficult for us to complete future acquisitions. |
In addition, we may have imposed upon us burdensome requirements, including:
| · | registration as an investment company; | |
| · | adoption of a specific form of corporate structure; and | |
| · | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations. |
In order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business other than investing, reinvesting or trading in securities and that our activities do not include investing, reinvesting, owning, holding or trading “investment securities” constituting more than 40% of our total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis.
As of September 30, 2026, investment securities, consisting principally of the Omnitek warrants and option received as advisory fees and purchased in a private placement, together with our interest in Rift, represented approximately 91% of our total assets exclusive of cash items. If we continue to receive fees in the form of securities or make additional investments, we may be unable to satisfy the 40% test and would need to rely on an exclusion or exemption, such as the exclusion for companies primarily engaged in a business other than investing in securities. If we were required to register as an investment company, we would be subject to the restrictions and requirements described above, which would be inconsistent with our strategy.
| 35 |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Recent Sales of Unregistered Securities
On July 20, 2026, in connection with an advisory agreement with an investment banking firm, we sold warrants to purchase an aggregate of 14,000,000 shares of common stock to that firm and fifteen of its designees at a purchase price of $0.01 per warrant, for aggregate proceeds of $140,000. The warrants have an exercise price of $0.01 per share, permit cashless exercise and expire on December 31, 2026. The sale was previously reported in our Current Report on Form 8-K filed on July 22, 2026, as amended on July 23, 2026. The warrants were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). As described in our 2026 Form 10-K, we are presently not able to rely on the exemption from registration provided under Rule 506 of Regulation D. We used the proceeds for general corporate purposes.
On July 14, 2026, we agreed to issue 250,000 shares of restricted common stock to investor relations consultant as partial compensation for investor relations services under an Investor Relations Agreement. The shares had a grant-date fair value of $35,598 and had not been issued as of the date of this report. The shares will be issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act.
Issuer Purchases of Equity Securities
None.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
Rule 10b5-1 Trading Arrangements
During the quarter ended September 30, 2026, none
of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act)
Cybersecurity
There have been no material changes to our cybersecurity risk management, strategy or governance from those described in Part I, Item 1C of our 2026 Form 10-K. During the quarter ended September 30, 2026, we did not identify any cybersecurity incident that has materially affected, or is reasonably likely to materially affect, us, including our business strategy, results of operations or financial condition.
Amendment of Compensatory Arrangements of Certain Officers
On November 15, 2026, the Company entered into amendments to the at-will employment offer letters dated September 1, 2026 with David Wachsman, its President and principal executive officer, and Q. Byron Hamlett, its Vice President and Chief Financial Officer and principal financial officer. Under the original letters, Mr. Wachsman’s annual base salary of $360,000 and Mr. Hamlett’s annual base salary of $270,000 were to begin upon the Company’s completion of additional fundraising, and Company-paid medical coverage, is deferred until the later of January 1, 2027 and the Company’s completion of additional fundraising. The amendments did not change either officer’s annual base salary or the at-will nature of employment. No compensation was earned or accrued under the offer letters as of September 30, 2026. The Company’s two other employees, including Derek Wachsman, Vice President and the brother of Mr. Wachsman, agreed to the same deferral on the same date. The foregoing description is qualified in its entirety by reference to the amended offer letters, which are filed as Exhibits 10.1 and 10.2 to this Quarterly Report on Form 10-Q and are incorporated herein by reference.
| 36 |
Item 6. Exhibits.
| Exhibit | Description |
| 10.1#* | Amended Employment Offer Letter, dated November 15, 2026, between the Company and David Wachsman |
| 10.2#* | Amended Employment Offer Letter, dated November 15, 2026, between the Company and Quinton Byron Hamlett |
| 31.1* | Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) |
| 31.2* | Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) |
| 32.1** | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350 |
| 32.2** | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350 |
| 101.INS | Inline XBRL Instance Document (embedded within the Inline XBRL document) |
| 101.SCH/CAL/DEF/LAB/PRE | Inline XBRL Taxonomy Extension Schema, Calculation, Definition, Label and Presentation Linkbase Documents |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
* Filed herewith. ** Furnished herewith. # Management contract or compensatory plan or arrangement.
| 37 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| HAWKEYE DIGITAL, INC. | |
| Date: November 16, 2026 | By: /s/ David Wachsman |
| David Wachsman, President (Principal Executive Officer) | |
| Date: November 16, 2026 | By: /s/ Q. Byron Hamlett |
| Q. Byron Hamlett, Chief Financial Officer (Principal Financial and Accounting Officer) |
| 38 |